BARRINGTON, Illinois (February 9, 2021) – Although rosacea sufferers now have access to more treatment options and sophisticated care than ever before, many are still untreated or using older therapies that may not be optimally suited for their individual cases.
BARRINGTON, Illinois (January 26, 2021) — Although many of the most commonly prescribed treatments for rosacea are oral or topical antibiotics, a recent survey by the National Rosacea Society (NRS) found the majority of rosacea patients have never heard of antibiotic resistance — the development of harmful bacteria unaffected by antibiotics.
BARRINGTON, Illinois (Nov. 23, 2020) — The National Rosacea Society has awarded funding for two new studies, in addition to continuing support for one ongoing study, as part of its research grants program to increase knowledge and understanding of the potential causes and other key aspects of rosacea that may lead to improvements in its treatment, prevention or potential cure.
BARRINGTON, Illinois (October 5, 2020) — A recent National Rosacea Society (NRS) survey found that most rosacea patients were satisfied with the oral and topical prescription therapies they are using to treat this chronic facial skin disorder, but that individuals 60 and over were more likely to use older treatments, rather than newer products that may more effectively target specific signs and symptoms.
BARRINGTON, Illinois (May 11, 2020) — New developments in rosacea call for dermatologists to place greater emphasis on addressing persistent facial erythema, according to experts at a recent National Rosacea Society (NRS) roundtable to provide an update on this key aspect of the disorder, based on the new standard classification system, recent burden-of-illness study results, new standard management options and significant advances in medical therapy and patient care.
CHICAGO (April 1, 2020) – Increased medical understanding has led to significant advances in the control of rosacea, allowing many of those who suffer from this chronic red-faced disorder to live free of its conspicuous and embarrassing symptoms for the first time.
BARRINGTON, Illinois (February 19, 2020) — A new generation of therapies has resulted in dramatic advances in the management of rosacea, allowing many of the estimated 16 million Americans who suffer from this chronic disorder to live free of its often life-disruptive signs and symptoms. The National Rosacea Society (NRS) has designated April as Rosacea Awareness Month to educate the public on the current understanding of this complex condition, urging those who believe they may have rosacea to see a dermatologist for diagnosis and appropriate therapy.
BARRINGTON, Illinois (August 14, 2019) — The National Rosacea Society has introduced an innovative public service booklet called “Recognizing Redness” to help rosacea sufferers assess facial redness, the primary diagnostic feature of this chronic facial skin disorder that affects more than 16 million Americans. The booklet includes a redness register to allow patients to gauge relative redness before and after flare-ups or treatment.
BARRINGTON, Illinois (June 3, 2019) — A recent National Rosacea Society (NRS) survey found that highly successful medical treatment for rosacea often has a major positive impact on patients’ lives.
In the survey of 1,044 rosacea patients, around 76 percent of all respondents saw at least some improvement in their skin after receiving treatment. Among those patients, 40 percent said that treatment had improved their psychological well-being, 35 percent said their social well-being had improved, and 31 percent saw improvement in their occupational well-being.
CHICAGO (April 1, 2019) – Rosacea can be a vicious cycle. The more you worry about its dreaded appearance, the likelier the stress may cause it to come crashing in at the worst possible time, showing up in the most conspicuous and embarrassing place—the face—as a redness that won’t go away, often with unsightly bumps and pimples. Fortunately today, rosacea sufferers have more reason than ever to be optimistic.
BARRINGTON, Illinois (February 11, 2019) – Although a cure for rosacea has yet to be discovered, advances in medical therapy have made it increasingly possible for those who suffer from this chronic disorder to achieve clear skin. At the same time, recent surveys have shown just how important this attainable goal is to patients’ physical and mental well-being.
BARRINGTON, Illinois (December 6, 2018) — The National Rosacea Society (NRS) announced today that new grants are available in 2019 to support research into potential causes and other key aspects of rosacea that may lead to improvements in its management, prevention or potential cure.
BARRINGTON, Illinois (July 11, 2018) — How many people in the world have rosacea? Researchers have attempted for the first time to determine the global prevalence of this widespread facial skin disorder, and the answer is estimated to be 415 million.
CHICAGO (April 2, 2018) – Facial redness that doesn’t go away? Inexplicable bumps and pimples? Irritated eyes? All are signs of rosacea, a potentially serious disorder that can now be diagnosed with more precision than ever before. April has been designated as Rosacea Awareness Month to educate the public on this often life-disruptive condition now affecting more than 16 million Americans – and most of them don’t know it.
BARRINGTON, Illinois (February 1, 2018) – When the National Rosacea Society (NRS) published the first standard classification of rosacea 15 years ago, it ushered in an unprecedented era of research into the disease process of this widespread chronic disorder of the facial skin – and now the first update has been published based on these dramatic advances in scientific knowledge.1 The NRS has designated April as Rosacea Awareness Month to educate the public on the current understanding of this often life-disruptive condition estimated to affect more than 16 millio
Click image for high-resolution version
Click image for high-resolution version
BARRINGTON, Illinois (November 8, 2017) – The National Rosacea Society (NRS) announced today that a new standard classification and pathophysiology of rosacea has been published in the Journal of the American Academy of Dermatology.1 Developed by a consensus committee and review panel of 28 rosacea experts worldwide, the updated system is based on the substantial advances in the understanding of rosacea gained through scientific investigations over the last 15 years.
BARRINGTON, Illinois (October 16, 2017) — The National Rosacea Society (NRS) announced it has awarded funding for three new studies, in addition to continuing support for three ongoing studies, as part of its research grants program to increase knowledge and understanding of the causes and other key aspects of rosacea that may lead to improvements in its management, prevention or potential cure.
